By Marisa Moura Momoli
29 de May de 2020
Biologics and biosimilars in Brazil – the strategic questions
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Last by Marisa Moura Momoli
15 de April de 2025
Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required
The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to … Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required
2 de December de 2024
Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty
On November 27, 2024, the Chamber of Deputies approved Bill 466/2022, which addresses Brazil’s adhesion to the Budapest Treaty on the International … Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty
9 de September de 2024
Kasznar Leonardos wins LMG Life Sciences
We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! … Kasznar Leonardos wins LMG Life Sciences